share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director BROWN C DAVID II

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director BROWN C DAVID II

西维斯健康 | 4:持股变动声明-董事 BROWN C DAVID II
美股sec公告 ·  05/17 17:39
Moomoo AI 已提取核心信息
On May 16, 2024, BROWN C DAVID II, reported a completed transaction of purchasing 2,314 shares of CVS Health Corp (CVS) common stock at a price of $57.52 per share. Following this transaction, BROWN C DAVID II directly holds a total of 121,434 shares in the company. The transaction, which involved direct ownership, was classified as a grant, award, or other acquisition, according to the transaction code description.
On May 16, 2024, BROWN C DAVID II, reported a completed transaction of purchasing 2,314 shares of CVS Health Corp (CVS) common stock at a price of $57.52 per share. Following this transaction, BROWN C DAVID II directly holds a total of 121,434 shares in the company. The transaction, which involved direct ownership, was classified as a grant, award, or other acquisition, according to the transaction code description.
2024年5月16日,BROWN C DAVID II报告完成了以每股57.52美元的价格购买2314股CVS Health Corp(CVS)普通股的交易。在这笔交易之后,BROWN C DAVID II直接持有该公司共计121,434股股份。根据交易代码的描述,该交易涉及直接所有权,被归类为赠款、奖励或其他收购。
2024年5月16日,BROWN C DAVID II报告完成了以每股57.52美元的价格购买2314股CVS Health Corp(CVS)普通股的交易。在这笔交易之后,BROWN C DAVID II直接持有该公司共计121,434股股份。根据交易代码的描述,该交易涉及直接所有权,被归类为赠款、奖励或其他收购。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息